AGA is seeking public comments on the new AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis. For your first look at this guideline, visit the link below and submit your feedback by completing the survey. Please submit your comments by Nov. 16.
About the public comment period
AGA develops clinical practice guidelines using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology, which provides a common, sensible and transparent approach to grading the quality of evidence and strength of recommendations, and uses the best practices outlined by the Institute of Medicine.
The public comment period is an integral part of AGA’s guideline development process. It allows AGA members and key stakeholders to review and comment on upcoming guidelines and their accompanying technical reviews.
Once an AGA guideline panel releases the drafts for public comment, identified stakeholders are alerted and submit their comments through an online survey. After the period ends, the guideline panel reviews and responds to the comments within two weeks. Revisions to the draft documents are at the discretion of the panel, but all comments will be considered and responses internally documented.
Learn more about AGA’s clinical practice guidelines.
